Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaya Diagnostic CentreBOM:543350 +5.97%84 PE Ratio (TTM) is 83.08 as of Aug. 13, 2026, which is 41% above its 10-year median of 58.88. GuruFocus rates BOM:543350 with a GF Score™ of 84/100 and a GF Value™ of ₹1,242.74 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 96 Medical Diagnostics & Research companies, Vijaya Diagnostic Centre ranks worse than 84.38% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-13), Vijaya Diagnostic Centre's share price is
₹1511.25.
Vijaya Diagnostic Centre's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ₹18.19. Therefore, Vijaya Diagnostic Centre's PE Ratio (TTM) for today is 83.08.
Warning Sign:
Vijaya Diagnostic Centre Ltd stock PE Ratio (=83.08) is close to 1-year high of 83.08.
The historical rank and industry rank for Vijaya Diagnostic Centre's PE Ratio (TTM) or its related term are showing as below:
BOM:543350'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 30.66 Med: 58.88 Max: 94.19
Current: 83.08
During the past 8 years, the highest PE Ratio (TTM) of Vijaya Diagnostic Centre was 94.19. The lowest was 30.66. And the median was 58.88.
BOM:543350's PE Ratio (TTM) is ranked worse than 84.38% of 96
companies
in the Medical Diagnostics & Research industry
Industry Median: 32.695
vs BOM:543350: 83.08
During the past 12 months, Vijaya Diagnostic Centre's average EPS without NRIGrowth Rate was 23.60% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 28.50% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 14.40% per year.
During the past 8 years, Vijaya Diagnostic Centre's highest 3-Year average EPS without NRI Growth Rate was 36.70% per year. The lowest was 8.90% per year. And the median was 13.70% per year.
Vijaya Diagnostic Centre (BOM:543350) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Vijaya Diagnostic Centre PE Ratio (TTM) Related Terms
Vijaya Diagnostic Centre PE Ratio (TTM) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543350 vs TMO, DHR, IDXX: PE Ratio (TTM) Comparison
For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaya Diagnostic Centre PE Ratio (TTM) vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Vijaya Diagnostic Centre's PE Ratio (TTM) falls into.
Vijaya Diagnostic Centre PE Ratio (TTM) Calculation
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Vijaya Diagnostic Centre's Share Price of today is ₹1511.25.
Vijaya Diagnostic Centre's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹18.19.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Vijaya Diagnostic Centre (BOM:543350) has a PE Ratio (TTM) of 83.08 as of Aug. 13, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Vijaya Diagnostic Centre and its competitors. This is 41% above median its historical median of 58.88. Over the past decade, Vijaya Diagnostic Centre's PE Ratio (TTM) has ranged from 30.66 to 94.19. According to the industry distribution chart, Vijaya Diagnostic Centre ranks #81 out of 96 companies in the Medical Diagnostics & Research industry, placing it in the top 84.4%.
Is Vijaya Diagnostic Centre's PE Ratio (TTM) too high?
Vijaya Diagnostic Centre's current PE Ratio (TTM) of 83.08 is 41% above median its 10-year median of 58.88. Over the past 10 years, this metric has ranged from a low of 30.66 to a high of 94.19. The Medical Diagnostics & Research industry median PE Ratio (TTM) is 32.70. Vijaya Diagnostic Centre's value of 83.08 is 154.1% above this industry median. Based on the distribution chart, Vijaya Diagnostic Centre ranks #81 out of 96 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Vijaya Diagnostic Centre has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vijaya Diagnostic Centre's PE Ratio (TTM) compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vijaya Diagnostic Centre ranks #81 out of 96 companies for PE Ratio (TTM). This places Vijaya Diagnostic Centre in the lower half of its industry. The industry median PE Ratio (TTM) is 32.70. Vijaya Diagnostic Centre's value of 83.08 is 154.1% above this benchmark. Historically, Vijaya Diagnostic Centre's own PE Ratio (TTM) has ranged from 30.66 to 94.19 over the past decade. While the company's 10-year median is 58.88 vs. the industry median of 32.70, Vijaya Diagnostic Centre has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Diagnostics & Research company?
The median PE Ratio (TTM) among Medical Diagnostics & Research companies is 32.70, based on 96 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaya Diagnostic Centre's current PE Ratio (TTM) of 83.08 is 154.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Vijaya Diagnostic Centre and its competitors. For the Medical Diagnostics & Research industry, the median PE Ratio (TTM) is 32.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaya Diagnostic Centre's current PE Ratio (TTM) is 83.08, which is 41% above median its own 10-year median of 58.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaya Diagnostic Centre stock overvalued right now?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre (BOM:543350) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,242.74, compared to a current price of ₹1,511.25 — trading 21.6% above its estimated fair value. The current PE Ratio (TTM) is 83.08, which is 41% above median its 10-year median of 58.88 and 154.1% above the Medical Diagnostics & Research industry median of 32.70. Vijaya Diagnostic Centre's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Vijaya Diagnostic Centre (BOM:543350), the current PE Ratio (TTM) is 83.08 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vijaya Diagnostic Centre (BOM:543350) Overvalued in 2026?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre stock appears to be overvalued.
The current stock price of ₹1,511.25 is trading 21.6% above its estimated GF Value™ of ₹1,242.74.
GuruFocus considers Vijaya Diagnostic Centre to be Modestly Overvalued.
Key valuation signals for BOM:543350:
PE Ratio (TTM): 83.08 (41% above median its 10-year median of 58.88)
GF Value™: ₹1,242.74 vs. price of ₹1,511.25 (21.6% above fair value)
Industry Position: 154.1% above the Medical Diagnostics & Research median (#81 of 96)
No single metric tells the full story. See the BOM:543350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.
84GF Score
Get the complete analysis for BOM:543350
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543350 has been successfully added to your 
